News
News Center
Jiuzhitang Maker wins two major awards at the "2021 Brand Powerhouse Economic Forum (5th Edition)"
2022-01-11
On January 7, 2022, the "2021 Brand Power Economic Forum & (5th) Innovation Achievement Promotion Event" was held in Hainan. The event was jointly organized by the China Economic & Trade Herald Magazine of the National Development and Reform Commission, the China International Brand Strategy Research Center at the University of International Business and Economics, the Organizing Committee for the Science and Technology Fair’s China Innovation and Economic Integration Achievement Promotion Event, and the Beijing Brand Association, among other institutions.
To recognize outstanding Chinese enterprises that have significantly contributed to economic development through innovation over the past year, boldly pursued the path of strengthening national brands, and achieved remarkable milestones in their respective fields, this year’s event builds on the success of the previous four editions. Leveraging online public sentiment analysis, the event has selected a group of exemplary leaders in economics, branding, and innovation as role models for progress. Jiuzhitang Maker was invited to attend and proudly secured two prestigious awards: "Top 100 Innovative Enterprises in China 2021" and "Top 10 Innovative Enterprises in the Biopharmaceutical Industry 2021."
This evaluation assessed applicant companies across dimensions such as "technological innovation, brand building, and reputation." Jiuzhitang Maker’s simultaneous win of two major awards underscores the industry’s leading media outlets, experts, and associations—along with their recognition—of the company’s strong brand influence and robust capabilities in the stem-cell field.
During the event, the organizers also proudly unveiled the "2021 China Brand Economy Innovation and Development Public Opinion Monitoring Results Evaluation Report." The report highlights that the world has now entered the era of the brand economy, and China is actively vying for influence by emphasizing "professionalism" and "standardization," while simultaneously boosting its national brands. Additionally, the report underscores that "going global" for brands begins with establishing robust standards—China has already issued 38 national standards specifically for brand evaluation. As a result, a nationally recognized brand evaluation mechanism and system, characterized by being "scientific, fair, transparent, and widely accepted," have largely taken shape. Nevertheless, China’s journey toward strengthening its own brands remains challenging, underscoring that building high-quality brands is still a long and arduous road ahead.
Since its establishment, Jiuzhitang Maker has placed great emphasis on brand-building efforts. Not only has it established a comprehensive self-media platform and an all-encompassing media dissemination network, but it has also actively collaborated with mainstream media outlets, key industry publications, and industry associations—becoming a member of multiple industry associations and serving as a committee member in specialized committees, while actively participating in the development of industry standards. In November 2021, Participated in the drafting of the group standard "Ethical Assessment Guidelines for Stem Cell Sources." , the guideline was led by the China Association of Medical Biotechnology, and only two companies were invited as drafting units: Fosun Pharma and Jiuzhitang Maker.
In addition, Jiuzhitang Maker was also recognized by the industry media MedPulse Star List. 2021 China Biopharmaceutical Company Most Promising Growth Award “The ‘Top 50 Most Innovative Chinese Biopharmaceutical Companies 2020’ award, along with the ‘2020 Outstanding Corporate Social Responsibility Award’ presented by Health News, among other prestigious media accolades.”
Innovation drives development, and brands shape the future. Jiuzhitang Maker will continue to leverage innovation as its driving force and build on our strong brand foundation to lead industry growth—and contribute our part in accelerating the launch of stem-cell therapies in the domestic market!
Related News
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy